Use of the laryngeal tube (LT) for out-of-hospital cardiac arrest (OHCA) by paramedics in Singapore leads to poorer placement success and more complications as compared with laryngeal mask airway (LMA), a study has found.
Use of alpha blockers in patients with chronic kidney disease (CKD) appears to be both beneficial and detrimental, with a recent study linking it to lower risk of cardiac events and mortality but higher risk of kidney disease progression compared with alternative blood pressure-lowering medications.
Consumption of plant protein was associated with a lower risk of all-cause and cardiovascular disease (CVD) mortality, according to a systematic review and meta-analysis, suggesting that substituting foods high in animal protein with plant protein sources may correlate with longevity.
A polymer-free, thicker-strut, biolimus A9-eluting stent (BES) was not noninferior to a biodegradable-polymer, ultrathin-strut, sirolimus-eluting stent (SES) in unselected patients requiring percutaneous coronary intervention (PCI), the SORT OUT* IX trial has shown.
Cycling was associated with reduced risk for both all-cause and cardiovascular (CV) mortality in people with diabetes, according to a study presented at EASD 2020 Meeting — suggesting that cycling could be encouraged as an activity to prevent deaths in this population who are known to have a higher mortality risk than the general public.
One way how hormone therapy with oestradiol may slow the progression of atherosclerotic cardiovascular disease (CVD) in postmenopausal women is through the reduction of inflammatory biomarkers, according to the ELITE* study presented at the NAMS 2020 Annual Meeting.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).